| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192256 | Annals of Allergy, Asthma & Immunology | 2010 | 7 Pages |
Abstract
Multiple unique characteristics were found to be associated with the requirement for subcutaneous immunotherapy dose adjustment, and this sample dose-adjustment protocol was not associated with an increased risk of a subsequent SR. The safety of this proposed dose-adjustment protocol should be confirmed in future prospective studies.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Christopher M. MD, Christopher W. MD,